Potential issues with implementation of EASL-EASD-EASO guidelines on management of MASLD in patients with type 2 diabetes in Sweden

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Journal of Hepatology Pub Date : 2025-02-19 DOI:10.1016/j.jhep.2025.02.018

Merle Roeren, Emilie Toresson Grip, Helena Skröder, Ying Shang, Hannes Hagström

{"title":"Potential issues with implementation of EASL-EASD-EASO guidelines on management of MASLD in patients with type 2 diabetes in Sweden","authors":"Merle Roeren, Emilie Toresson Grip, Helena Skröder, Ying Shang, Hannes Hagström","doi":"10.1016/j.jhep.2025.02.018","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors' contributions</h2>HH designed the study. ETG, HS, MR, YS and HH performed data analyses. MR wrote the manuscript with input from all authors. MR, YS and HH revised the manuscript. All the authors contributed to discussion.</section></section><section><section><h2>Financial support</h2>HH was supported by grants from the Swedish Research Council, the Swedish Cancer Society and Region Stockholm (CIMED). YS was supported by grants from Region Stockholm (CIMED).</section></section><section><section><h2>Declaration of Competing Interest</h2>HH:s institutions have received research funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD, Novo Nordisk and Pfizer. HH has served as consultant or on advisory boards for Astra Zeneca, Bristol Myers-Squibb, MSD and Novo Nordisk and has been part of hepatic events adjudication committees for Arrowhead, Boehringer Ingelheim, KOWA and GW Pharma.Please refer to the accompanying ICMJE disclosure forms for further details.</section></section><section><section><h2>Acknowledgements</h2>The authors would like to thank the staff of the National Diabetes Register and all the study participants.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"2 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.02.018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors' contributions

HH designed the study. ETG, HS, MR, YS and HH performed data analyses. MR wrote the manuscript with input from all authors. MR, YS and HH revised the manuscript. All the authors contributed to discussion.

Financial support

HH was supported by grants from the Swedish Research Council, the Swedish Cancer Society and Region Stockholm (CIMED). YS was supported by grants from Region Stockholm (CIMED).

Declaration of Competing Interest

HH:s institutions have received research funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD, Novo Nordisk and Pfizer. HH has served as consultant or on advisory boards for Astra Zeneca, Bristol Myers-Squibb, MSD and Novo Nordisk and has been part of hepatic events adjudication committees for Arrowhead, Boehringer Ingelheim, KOWA and GW Pharma.Please refer to the accompanying ICMJE disclosure forms for further details.

Acknowledgements

The authors would like to thank the staff of the National Diabetes Register and all the study participants.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.